Indonesia - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingIndonesia: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024
Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Indonesia
The Indonesian market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X in 2023, remaining constant against the previous year. In general, consumption, however, enjoyed a strong increase. Consumption of peaked at $X in 2021; afterwards, it flattened through to 2023.
Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Indonesia
In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses reached $X in 2023 estimated in export price. Overall, production, however, saw strong growth. The pace of growth was the most pronounced in 2020 when the production volume increased by X% against the previous year. Over the period under review, production of attained the maximum level at $X in 2021; however, from 2022 to 2023, production stood at a somewhat lower figure.
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Exports from Indonesia
In 2023, overseas shipments of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses were finally on the rise to reach X tons after two years of decline. Over the period under review, exports, however, continue to indicate a significant contraction. The most prominent rate of growth was recorded in 2017 when exports increased by X% against the previous year. The exports peaked at X tons in 2012; however, from 2013 to 2023, the exports failed to regain momentum.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X in 2023. In general, exports, however, faced a abrupt decrease. The pace of growth was the most pronounced in 2020 when exports increased by X%. Over the period under review, the exports of attained the peak figure at $X in 2012; however, from 2013 to 2023, the exports remained at a lower figure.
Exports by Country
Australia (X tons), Nigeria (X tons) and Brazil (X tons) were the main destinations of exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses from Indonesia, together accounting for X% of total exports. Germany, Togo, Afghanistan, Thailand, Myanmar, Cambodia, the Philippines and Vietnam lagged somewhat behind, together comprising a further X%.
From 2012 to 2023, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Germany (with a CAGR of X%), while the other leaders experienced mixed trend patterns.
In value terms, the largest markets for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exported from Indonesia were Australia ($X), Brazil ($X) and Thailand ($X), together comprising X% of total exports. Nigeria, the Philippines, Togo, Afghanistan, Germany, Cambodia, Myanmar and Vietnam lagged somewhat behind, together accounting for a further X%.
Germany, with a CAGR of X%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
In 2023, the average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X per ton, falling by X% against the previous year. In general, the export price, however, posted significant growth. The pace of growth appeared the most rapid in 2020 an increase of X% against the previous year. The export price peaked at $X per ton in 2022, and then contracted rapidly in the following year.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Philippines ($X,962 per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to the Philippines (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Imports into Indonesia
In 2023, purchases abroad of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the sixth consecutive year after three years of decline. In general, imports continue to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2019 with an increase of X% against the previous year. Over the period under review, imports of hit record highs at X tons in 2014; however, from 2015 to 2023, imports failed to regain momentum.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses dropped slightly to $X in 2023. Over the period under review, total imports indicated noticeable growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, imports increased by X% against 2016 indices. The pace of growth was the most pronounced in 2021 with an increase of X% against the previous year. Over the period under review, imports of hit record highs at $X in 2022, and then contracted in the following year.
Imports by Country
In 2023, India (X tons) constituted the largest supplier of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses to Indonesia, with a X% share of total imports. Moreover, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses from India exceeded the figures recorded by the second-largest supplier, Oman (X tons), tenfold. The third position in this ranking was held by Thailand (X tons), with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of volume from India amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Oman (X% per year) and Thailand (X% per year).
In value terms, India ($X) constituted the largest supplier of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses to Indonesia, comprising X% of total imports. The second position in the ranking was taken by China ($X), with a X% share of total imports. It was followed by Switzerland, with an X% share.
From 2012 to 2023, the average annual growth rate of value from India stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: China (X% per year) and Switzerland (X% per year).
Import Prices by Country
In 2023, the average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X per ton, reducing by X% against the previous year. Overall, import price indicated a pronounced increase from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2015 an increase of X% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2017; however, from 2018 to 2023, import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was Poland ($X per ton), while the price for Hong Kong SAR ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Poland (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Indonesia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Indonesia
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Indonesia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in China.
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the EU.
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Asia.
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses Indonesia
- Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses Market
- Frozen and Fresh or Chilled Skipjack Tuna Market
- Frozen Market
- Frozen Scallops Market
- Jellyfish Market
- Non-Citrus Fruits not Elsewhere Classified Market
- Battered Fish Fillet Market
- Fluorine, Chlorine, Bromine and Iodine Market
- Crispbread Market